NVAX Novavax, Inc.

HealthcareBiotechnology
$10.11
▲ 9.53%
42
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
32
Short-Term
53

Value

18
P/E-18.79
8
P/B-11.40
5
P/S2.79
57
EV/EBITDA-30.33
5

Growth

69
Revenue Growth64.7%
100
EPS Growth321.1%
65
FCF Growth-149.4%
27

Momentum

90
12-Month Return69.9%
99
3-Month Return22.5%
96
1-Month Return18.4%
87
RSI (14)70.93
86
50/200 MABullish
75

Profitability

26
ROE89.7%
69
ROA-8.4%
0
Gross Margin84.6%
69
Operating Margin-11.2%
5
Net Margin-14.7%
4
FCF Yield-5.8%
0

Risk

9
Beta2.37
20
60-Day Volatility70.9%
0

Generated 5/9/2026, 9:17:49 AM · How is this calculated?

Get an email when the QScore signal flips. No daily noise.
QScore Analysis